Evaluation of the Epidemiological-Clinical and Psycho-Social aspects of Hypertensive Patients with COVID-19 at the Epidemiological Treatment Center of Gbessia Conakry

Coronavirus disease 2019 (COVID-19), is a global pandemic that has affected 600 million cases worldwide [1] and more than 3.3 million cases in Japan in February 2022 [2]. Its impact in patients with comorbidities with cardiovascular risk factors such as high blood pressure (HBP) is unpredictable. We aimed through this study to evaluate the psychological impact of COVID-19 in hypertensive patients hospitalized at the Gbessia epidemiological treatment center. We conducted a retrospective descriptive study from November 1, 2020 to April 30, 2021 covering all known or incidentally discovered hypertensive patients hospitalized at the Gbessia epidemiological treatment center for COVID-19. Hypertensive patients represented 16.11% with an average age of 58.25 23 years with a female predominance at 51%, 36.19% of patients did not present symptoms and in symptomatic forms the picture was dominated by asthenia (27.10%), dyspnea (20.95%), and fever (15.71%). The majority of patients (49.05%) were in Grade 1 of High Blood Pressure (WHO). The study showed that the psychological impact was marked by an anxiety-depressive state in the majority of cases (62%). This psychological state showed a favorable evolution in the vast majority of our patients (81%). It should be noted through this study that the level of anxiety and depression linked to COVID-19 infection in hypertensive patients is not negligible and this must be a considerable element in the management of these patients.